Dr Alexandra Stolzing has her main research team in Loughborough, UK where she works as a Senior Lecturer. In the past, she served as the Head of Stem Cell Biology Group at the Fraunhofer Institute for Cell Therapy and Immunology. She completed her PhD degree at the Humboldt University of Berlin.
With over fifteen years in ageing and regenerative medicine research fields Alexandra brings incredibly rich and valuable insight to CellAge. Some of her achievements include developing a new way of creating iPS cells for clinical use to help develop therapies for ageing as well as developing stem cell treatments for Alzheimer’s disease. Alexandra has published over 55 peer-reviewed research papers